Panagora Asset Management Inc Blueprint Medicines Corp Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Panagora Asset Management Inc holds 96,806 shares of BPMC stock, worth $8.76 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

96,806

Previous 147,564 34.4%

Holding current value

$8.76 Million

Previous $15.9 Million 43.72%

% of portfolio

0.04%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$84.1 - $120.5 $4.27 Million - $6.12 Million	-50,758 Reduced 34.4%	96,806 $8.95 Million
Q2 2024 Jul 29, 2024	SELL	$85.18 - $108.78 $9.87 Million - $12.6 Million	-115,910 Reduced 43.99%	147,564 $15.9 Million
Q1 2024 May 07, 2024	SELL	$73.17 - $99.79 $514,824 - $702,122	-7,036 Reduced 2.6%	263,474 $25 Million
Q4 2023 Feb 08, 2024	BUY	$43.96 - $92.84 $313,083 - $661,206	7,122 Added 2.7%	270,510 $25 Million
Q3 2023 Oct 31, 2023	SELL	$46.9 - $66.0 $277,788 - $390,918	-5,923 Reduced 2.2%	263,388 $13.2 Million
Q2 2023 Aug 11, 2023	SELL	$42.2 - $66.37 $212,266 - $333,841	-5,030 Reduced 1.83%	269,311 $17 Million
Q1 2023 May 11, 2023	BUY	$37.97 - $50.0 $1.47 Million - $1.94 Million	38,747 Added 16.45%	274,341 $12.3 Million
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $1.18 Million - $1.91 Million	28,701 Added 13.87%	235,594 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $1.34 Million - $2.09 Million	26,862 Added 14.92%	206,893 $13.6 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $24,876 - $38,582	-550 Reduced 0.3%	180,031 $9.09 Million
Q1 2022 May 12, 2022	BUY	$54.1 - $110.08 $209,204 - $425,679	3,867 Added 2.19%	180,581 $11.5 Million
Q4 2021 Feb 10, 2022	BUY	$94.25 - $115.99 $2.98 Million - $3.67 Million	31,654 Added 21.82%	176,714 $18.9 Million
Q3 2021 Nov 10, 2021	BUY	$80.98 - $109.47 $11.5 Million - $15.6 Million	142,464 Added 5487.83%	145,060 $14.9 Million
Q2 2021 Aug 11, 2021	BUY	$82.78 - $101.0 $214,896 - $262,196	2,596 New	2,596 $228,000
Q4 2019 Feb 12, 2020	SELL	$66.73 - $82.59 $2.14 Million - $2.64 Million	-32,014 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$73.54 - $97.8 $2.35 Million - $3.13 Million	32,014 New	32,014 $3.02 Million
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $42,184 - $70,016	-692 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $1,758 - $2,470	-24 Reduced 3.35%	692 $63,000
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $45,043 - $63,237	716	716 $54,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Blueprint Medicines Corp Transaction History